35
BigHat Biosciences, Inc. files Form D
Company raise update · Closed · Offering $124.1M · Sold $124.1M · SAN MATEO, CA · filed 2025-04-28
55
BigHat Biosciences raises $80M under Reg D 506(b) in San Mateo
Company raise · Raising · SAN MATEO, CA · Form D filed 2026-10-26
BigHat Biosciences, a Delaware biotech corporation, is raising $80M and has sold $75.14M to 29 investors as of October 2026. The offering is nearly complete with $4.86M remaining and first sales began in July 2026.
$50M+ raiseother
How this compares
- Among 1,633 fund launches filed from CA in the same window it is larger than 76%; the CA median is $19M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-04-28 | D/A | $124.1M | 40 | |
| 2026-10-26 | D | $75.1M | 29 | −$49M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Bighat Biosciences on EDGAR
Earlier and related filings by the same issuer and sponsor.
People on the filing
| Peyton Greenside | Executive Officer, Director |
| Vineeta Agarwala | Director |
| Robert Chess | Director |
| Francisco Gimenez | Director |
| Andrew Conrad | Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Peyton Greenside, Chief Executive Officer.
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.